Clinical Trial

L-Citrulline Versus Tamsulosin for Medical Expulsive Therapy of Distal Ureteral Stones

Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
This study will compare L-citrulline and tamsulosin as medical expulsive therapy for adults with single distal ureteral stones. Eligible participants with a single distal ureteral stone measuring 5 to 10 mm will be randomly assigned to receive either oral L-citrulline 750 mg twice daily or oral tamsulosin 0.4 mg once daily. Treatment will continue until documented stone passage or completion of 4 weeks of therapy, whichever occurs first. Participants will be followed weekly for up to 4 weeks. The main outcome is stone expulsion within 4 weeks. The study will also assess time to stone expulsion, pain episodes, analgesic use, need for additional intervention, and adverse events.
Trial Details
NCT Number NCT07617909
Lead Sponsor Beni-Suef University
Conditions Distal Ureteral Stone, Urolithiasis, Ureteral Calculi
Enrollment 120 participants
Start Date 2026-05-06
Primary Completion 2026-10 (estimated)
Study Completion 2026-11 (estimated)
Updated on ClinicalTrials.gov 2026-06-01